Lauren Wells
Gerontology · Pleasant View, TNNPI 1316682750
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 91.2% of the total across 53 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 13 manufacturers reported payments, led by AbbVie at 33.4% of the total. Reporting peaked in 2023 at $647 and has fallen 91.4% since, to $55 in 2025.
Across 53 payments — averaging $20.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$360
- Astellas Pharma US Inc$194
- Novo Nordisk$122
- AstraZeneca$101
- Lilly USA, LLC$70
- Acadia Pharmaceuticals Inc$45
- plus $185 from 7 others
What the payments were for
- Food & beverage$98291%
- Education$959%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 21 | $360 |
| Astellas Pharma US Inc | 5 | $194 |
| Novo Nordisk | 6 | $122 |
| AstraZeneca | 6 | $101 |
| Lilly USA, LLC | 4 | $70 |
| Acadia Pharmaceuticals Inc | 1 | $45 |
| Bayer | 2 | $45 |
| GSK | 3 | $39 |
| Endo USA, Inc. | 1 | $30 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $22 |
| Exact Sciences | 1 | $17 |
| Pfizer | 1 | $17 |
| Insulet Corporation | 1 | $16 |
How this compares
$1,077 in reported general payments places this provider in the 75th percentile of 194 gerontology providers in Tennessee.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 28 | $34,431 |
| EliquisApixaban | 40 | $18,567 |
| FarxigaDapagliflozin Propanediol | 19 | $14,239 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 12 | $8,696 |
| Pregabalin | 67 | $2,803 |
| Levemir FlexpenInsulin Detemir | 12 | $2,099 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 43 | $1,840 |
| Gabapentin | 100 | $1,423 |
| Duloxetine Hcl | 40 | $1,410 |
| Atorvastatin Calcium | 122 | $1,304 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 82 | $1,017 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 22 | $918 |
| Losartan Potassium | 106 | $784 |
| Omeprazole | 65 | $769 |
| Losartan-HydrochlorothiazideLosartan/Hydrochlorothiazide | 23 | $754 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $122 | $34,43128 claims |
| AstraZenecaFarxiga, Breztri Aerosphere | $101 | $22,93531 claims |
| PfizerEliquis | $17 | $18,56740 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 194 gerontology providers in Tennessee.
Other gerontology in Pleasant View
- Sarah VannPleasant View$2K
- Jennifer MurffPleasant View$2K
- David HughesKnoxville$476K
- Melissa RossGermantown$15K
- Erann BulmanKnoxville$13K
- Leah BalchGreeneville$9K
- Xiaoxiao ZhangNashville$8K
- Ashley WoodKnoxville$6K
- Erica LudtkeNashville$6K
- Sara ErgerCookeville$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.